Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-11-17

Clinical Trial Update: Study of Bulevirtide in Participants With Chronic Hepatitis D Infection

View source ↗

Summary

A clinical trial update indicates bulevirtide is being studied for chronic hepatitis D infection, with the study currently active but not recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Bulevirtide (Hepcludex) (bulevirtide)

Snippet

Sponsor: Gilead Sciences | Conditions: Chronic Hepatitis D Infection | Status: ACTIVE_NOT_RECRUITING